Meeting People Where They’re At: Pharmacist-Led Innovations in Substance Use Care

After you listen please complete SAMHSA’s required Training and Technical Assistance (TTA) GPRA Post-Event Form. This form will gather satisfaction with the event to help improve future episodes.Medications for opioid use disorder (MOUD) are life-saving, yet three-quarters of people who need them still can't access them. Pharmacists are uniquely positioned to expand treatment, especially in rural communities and those with the fewest treatment options. Working collaboratively or independently, they can improve access, timing, and patient choice for MOUD care, starting where patients and medications already are. This episode examines how pharmacy-based models are closing gaps in addiction care deserts, how pharmacists can strengthen interdisciplinary care teams, and why fair reimbursement for pharmacist services matters for sustaining care in the communities hit hardest by overdose.Timestamps:[00:00:00] Welcome and Meet the Guests [06:41:00] Training Pharmacist Clinicians [09:42:00] Collaborative Practice Agreements [15:31:00] Holistic Primary Care Model [19:22:00] Patient Success Stories [26:31:00] Policy Shifts Enabling Prescribing [32:39:00] State Policy Map Resource [36:34:00] Stigma and Gatekeeping Mindset [39:23:00] Community Pharmacy Workflow Hurdles [41:50:00] Future Vision for MOUD AccessLinksAMERSAPharmacy BridgeBuprenorphine Prescribing Requirements and LimitationsFind us online at amersa.org/amersa-podcast Frontiers in Substance Use & Stigma & Substance Use are sponsored by Provider’s Clinical Support System – Medication for Opioid Use Disorder (PCSS-MOUD). Learn more about PCSS-MOUD at pcssnow.org.Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.Substance Use Across the Lifespan and Innovation in Action are sponsored by the Opioid Response Network (ORN). Learn more about ORN at opioidresponsenetwork.org.Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.